WMB:NYSEWilliams Companies, Inc. (The) Analysis
Data as of 2026-08-21 - not real-time
$71.68
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
The Williams Companies, Inc. is priced at $71.68, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 5.0%. RSI sits at 45.9, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $68.52 and resistance around $76.42.
The shares look overvalued, trading on 29.1 times earnings above a sector average of 21.5. The average analyst target implies 18.7% above today's level. Revenue is growing at 7.8% on a 24.9% profit margin. The 2.87% dividend yield looks stretched against payout coverage.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 28.1%, a beta of 0.02 and a maximum drawdown of 12.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
The shares look overvalued, trading on 29.1 times earnings above a sector average of 21.5. The average analyst target implies 18.7% above today's level. Revenue is growing at 7.8% on a 24.9% profit margin. The 2.87% dividend yield looks stretched against payout coverage.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 28.1%, a beta of 0.02 and a maximum drawdown of 12.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
Williams Companies agreed to acquire Momentum Midstream for up to $5.Seeking Alpha16dThe Williams Companies, Inc.Yahoo Finance24dWilliams Companies, Inc. The WMB Earnings Expected to Grow: Should You Buy?The above button links to...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 69.37
- MACD momentum is positive
- RSI at 45.9 is in neutral territory
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 29.1 versus sector average of 21.5
- Dividend yield of 2.87% looks stretched against payout coverage
- Trading above the 200-day average of 69.37
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 29.1 versus sector average of 21.5
- Dividend yield of 2.87% looks stretched against payout coverage
- Analyst targets imply +18.7% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin24.94%
P/E Ratio29.1
ROE21.50%
ROA5.03%
Debt/Equity200.37
P/B Ratio6.7
Op. Cash Flow$6.0B
Free Cash Flow$-1516749952
Industry P/E21.5
Technical Analysis
TrendNeutral
RSI45.9
Support$68.52
Resistance$76.42
MA 20$72.15
MA 50$73.35
MA 200$69.37
MACDBullish
VolumeDecreasing
Fear & Greed Index92.84
Valuation
Fair Value$36.46
Target Price$85.10
Upside/Downside18.72%
GradeOvervalued
TypeBlend
Dividend Yield2.87%
Risk Assessment
Beta0.02
Volatility28.12%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.